GPs allowed to approve continuous glucose monitors — but only for veterans
GPs can now approve fully funded continuous glucose monitors for veteran card holders despite their ban from approving the devices under the National Diabetes Services…
Tag: Endocrinology – Diabetes
‘Be wary of prescribing’ tirzepatide amid another diabetes drug shortage
Doctors should exercise caution when prescribing tirzepatide, a leading GP says, after a surge in demand sparked a supply shortage within two months of entering…
Diabetic foot ulcers: New guidelines ‘empower’ GPs to manage high-risk patients
Patients at moderate to high risk of diabetic foot ulcers require medical-grade footwear and should self-monitor foot skin temperatures daily for early signs of ulceration,…
Fasting glucose test for GDM screening could replace nearly 80% of OGTTs: Aussie doctors
Fasting blood glucose tests as an initial step in gestational diabetes screening could eliminate the need for oral glucose tolerance tests in most pregnant women,…
Time-restricted dieting beats calorie counting for weight loss in diabetes: study
Time-restricted dieting may be better for people with type 2 diabetes to lose weight than counting calories, a US study suggests. Researchers found that people…
Diabetes in NAFLD drives high rate of decompensated cirrhosis: Aussie study
One in three adults with NAFLD-related cirrhosis and diabetes in the decade up to 2018 progressed to decompensated cirrhosis, an Australian study shows. Age, hypertension and extrahepatic cancer all…
Pancreatitis risk rises with popular weight loss drugs: study
Patients using GLP-1 receptor agonists for weight loss are nine times more likely to develop pancreatitis than those taking bupropion–naltrexone, Canadian researchers say. Use of…
TGA investigates bowel obstruction risk with semaglutide
The TGA is investigating reports of intestinal obstruction in patients using semaglutide and may consider updating the product information to include a warning about ileus. …
TGA tightens Ozempic advice (again) as global shortage bites
The TGA is once again urging doctors against initiating patients on semaglutide, less than three months after relaxing its prescribing advice, as limited supply struggles…
New fast-acting insulin added to PBS to replace delisted drugs
Patients with types 1 diabetes will continue to have subsidised access to fast-acting insulin, with the approval of a new product to replace Fiasp and…
